Walsh & Associates’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
Walsh & Associates's GSK Position: Q3 2026 in Review
Walsh & Associates held its GSK (GSK) position steady in Q3 2026 at 80 shares worth $3.85K. The position accounts for ﹤0.01% of the portfolio, ranked #228.
Walsh & Associates first reported a position in GSK in Q4 2025 and has held it in 4 quarters since. The position peaked at $4.42K in Q1 2026. 992 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- Walsh & Associates held 80 shares of GSK worth $3.85K as of Q3 2026.
- Walsh & Associates left its GSK share count unchanged in Q3 2026.
- GSK made up ﹤0.01% of Walsh & Associates's portfolio in Q3 2026, its #228 holding.
- Walsh & Associates first reported a position in GSK in Q4 2025 and has held it in 4 quarters since.
- Walsh & Associates's GSK position peaked at $4.42K in Q1 2026.
- 992 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on Walsh & Associates's 13F filing for Q3 2026, filed 9 Nov 2026.